Vico Therapeutics

Vico Therapeutics company information, Employees & Contact Information

Explore related pages

Vico Therapeutics email format Vico Therapeutics management contacts

Related company profiles:

Vico Therapeutics is committed to advancing RNA modulating therapies for patients with severe, genetic neurological disorders. Vico is initially targeting spinocerebellar ataxia types 3 and 1 and Huntington’s disease. Our VICOMER platform designs antisense oligonucleotides for various genetic defects by modulating or editing RNA. For more information, visit www.vicotx.com

Company Details

Employees
48
Founded
-
Address
J.h. Oortweg 21, Leiden,south Holland 2333 Ch,netherlands
Phone
+31 71 2036800
Email
in****@****otx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
vicotx.com
Keywords
passion for RNA therapeutics are directly aligned with our mission. We’re excited to have him on board as we continue advancing allele-preferential ASO therapies for rare genetic neurological diseases..
HQ
Leiden, South Holland
Competitors
Harness Therapeutics, CAMP4 Therapeutics, VectorY, Hoth Therapeutics, Inc, Leyden Labs, uniQure, LAVA Therapeutics N.V., Amarna Therapeutics, GRIN Therapeutics, Inc., ProQR Therapeutics.
Looking for a particular Vico Therapeutics employee's phone or email?

Vico Therapeutics Questions

News

Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline - PR Newswire

Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline PR Newswire

Dutch Vico Therapeutics Strengthens Leadership Team with the Appointment of Rupert Sandbrink as Chief Medical Officer and Anders Hinsby as Independent Director - Biotech Newswire

Dutch Vico Therapeutics Strengthens Leadership Team with the Appointment of Rupert Sandbrink as Chief Medical Officer and Anders Hinsby as Independent Director Biotech Newswire

Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases - PR Newswire

Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases PR Newswire

Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer - PR Newswire

Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer PR Newswire

Companies like Vico Therapeutics

Harness Therapeutics logo - Similar company to Vico Therapeutics

Harness Therapeutics

33
uniQure logo - Similar company to Vico Therapeutics

Uniqure

311
Amarna Therapeutics logo - Similar company to Vico Therapeutics

Amarna Therapeutics

17
Leyden Labs logo - Similar company to Vico Therapeutics

Leyden Labs

89
VectorY logo - Similar company to Vico Therapeutics

Vectory

92
Hoth Therapeutics, Inc logo - Similar company to Vico Therapeutics

Hoth Therapeutics, Inc

8
GRIN Therapeutics, Inc. logo - Similar company to Vico Therapeutics

Grin Therapeutics, Inc.

3
LAVA Therapeutics N.V. logo - Similar company to Vico Therapeutics

Lava Therapeutics N.V.

36
CAMP4 Therapeutics logo - Similar company to Vico Therapeutics

Camp4 Therapeutics

64
ProQR Therapeutics logo - Similar company to Vico Therapeutics

Proqr Therapeutics

194

Top Vico Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant